<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>How Renewed Scrutiny of Pediatric Vaccine Safety at Moderna (MRNA) Has Changed Its Investment Story — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">How Renewed Scrutiny of Pediatric Vaccine Safety at Moderna (MRNA) Has Changed Its Investment Story</h2>
    <div class="badge">2025-09-16T11:06:34+00:00</div>
    <ul>
      <li>This requires 4.6% yearly revenue growth and a $3.4 billion increase in earnings from current earnings of -$2.9 billion.</li>
<li>Uncover how Moderna&#x27;s forecasts yield a $44.25 fair value , a 85% upside to its current price.</li>
<li>Read the full narrative on Moderna (it&#x27;s free!) Moderna&#x27;s narrative projects $3.5 billion revenue and $498.6 million earnings by 2028.</li>
<li>Story Continues MRNA Community Fair Values as at Sep 2025 Twenty-six members of the Simply Wall St Community estimate Moderna’s fair value between US$44.25 and US$186.49 a share.</li>
<li>Explore 26 other fair value estimates on Moderna - why the stock might be worth just $44.25!</li>
<li>In early September 2025, news emerged that Trump administration health officials planned to present claims linking COVID-19 vaccines to the deaths of about two dozen children, prompting heightened regulatory and public s</li>
<li>Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=How Renewed Scrutiny of Pediatric Vaccine Safety at Moderna (MRNA) Has Changed Its Investment Story\n• This requires 4.6% yearly revenue growth and a $3.4 billion increase in earnings from current earnings of -$2.9 billion.\n• Uncover how Moderna&#x27;s forecasts yield a $44.25 fair value , a 85% upside to its current price.\n• Read the full narrative on Moderna (it&#x27;s free!) Moderna&#x27;s narrative projects $3.5 billion revenue and $498.6 million earnings by 2028.\n• Story Continues MRNA Community Fair Values as at Sep 2025 Twenty-six members of the Simply Wall St Community estimate Moderna’s fair value between US$44.25 and US$186.49 a share.\n• Explore 26 other fair value estimates on Moderna - why the stock might be worth just $44.25!\n• In early September 2025, news emerged that Trump administration health officials planned to present claims linking COVID-19 vaccines to the deaths of about two dozen children, prompting heightened regulatory and public s\n• Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/renewed-scrutiny-pediatric-vaccine-safety-110634823.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>